Company Valuation: Chugai Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 9,045,924 6,141,311 5,540,406 8,789,053 11,516,953 15,091,192 15,091,192 -
Change - -32.11% -9.78% 58.64% 31.04% 31.03% 0% -
Enterprise Value (EV) 1 8,667,304 5,669,311 5,051,408 8,050,071 10,520,608 13,138,942 14,060,238 13,797,467
Change - -34.59% -10.9% 59.36% 30.69% 24.89% -0.95% -1.87%
P/E ratio 42.1x 20.3x 14.8x 27x 29.7x 31.3x 31.2x 27.2x
PBR 9.23x 5.17x 3.89x 5.41x 6.06x 6.7x 6.81x 5.97x
PEG - 0.5x 0.6x -2.1x 1.6x 2.6x 2.4x 1.9x
Capitalization / Revenue 11.5x 6.14x 4.4x 7.91x 9.84x 10.8x 11.2x 10.3x
EV / Revenue 11x 5.67x 4.01x 7.24x 8.99x 10.4x 10.5x 9.45x
EV / EBITDA 26.1x 12.3x 8.93x 17.1x 18.3x 20.4x 20.4x 17.7x
EV / EBIT 28.8x 13.4x 9.47x 18.3x 19.4x 21.9x 21.2x 18.2x
EV / FCF 81.2x 35.3x 27.7x 21.6x 47.8x 71x 31.1x 27.3x
FCF Yield 1.23% 2.83% 3.61% 4.63% 2.09% 1.41% 3.21% 3.66%
Dividend per Share 2 55 76 78 80 98 272 140.4 150.2
Rate of return 1% 2.03% 2.32% 1.5% 1.4% 3.3% 1.53% 1.64%
EPS 2 130.7 184.3 227.6 197.8 235.4 263.7 294.1 336.8
Distribution rate 42.1% 41.2% 34.3% 40.4% 41.6% 103% 47.8% 44.6%
Net sales 1 786,900 999,800 1,259,946 1,111,367 1,170,611 1,257,900 1,342,132 1,459,763
EBITDA 1 332,600 459,100 565,376 470,914 573,667 643,900 690,421 780,108
EBIT 1 301,200 421,900 533,309 439,174 542,002 598,800 661,717 756,180
Net income 1 214,700 303,000 374,429 325,472 387,317 434,000 483,991 554,210
Net Debt 1 -378,620 -472,000 -488,998 -738,982 -996,345 -426,602 -1,030,954 -1,293,725
Reference price 2 5,503.00 3,735.00 3,368.00 5,342.00 6,999.00 9,170.00 9,170.00 9,170.00
Nbr of stocks (in thousands) 1,643,817 1,644,260 1,645,014 1,645,274 1,645,514 1,645,713 1,645,713 -
Announcement Date 04/02/21 03/02/22 02/02/23 01/02/24 30/01/25 29/01/26 - -
1JPY in Million2JPY
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
35.26x11.38x22.37x2.76% 98.24B
31.01x11.75x23.61x0.64% 926B
24.77x6.01x16.36x2.18% 586B
65.02x7.68x19.02x2.81% 412B
19.35x4.81x11.94x2.72% 382B
33.11x5.93x17.67x1.55% 326B
21.99x6.1x15x2.65% 317B
15.7x5.03x10.98x2.66% 302B
14.77x5.12x10.74x3.51% 218B
25.23x6.36x11.23x2.69% 201B
Average 28.62x 7.02x 15.89x 2.42% 376.74B
Weighted average by Cap. 29.63x 7.51x 17.11x 2.07%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. 4519 Stock
  4. Valuation Chugai Pharmaceutical Co., Ltd.